nicergoline has been researched along with Cognitive Decline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bogolepova, AN | 1 |
| Bakulin, DA; Kovalenko, AL; Kurkin, DV; Kuznetsova, EV; Lycheva, NA; Morkovin, EI; Myagkova, IA; Robertus, AI; Shmidt, MV; Tarasov, AS | 1 |
| Ma, Z; Qiao, P; Wang, B; Zhong, L | 1 |
1 trial(s) available for nicergoline and Cognitive Decline
| Article | Year |
|---|---|
Clinical efficacy and safety of nicergoline combined with oxiracetam in the treatment of vascular cognitive impairment.
Topics: Adult; Aged; Aged, 80 and over; Cognitive Dysfunction; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicergoline; Pyrrolidines; Stroke; Treatment Outcome | 2020 |
2 other study(ies) available for nicergoline and Cognitive Decline
| Article | Year |
|---|---|
[Vascular cognitive impairment].
Topics: Alzheimer Disease; Cholinergic Agents; Cognitive Dysfunction; Dementia, Vascular; Humans; Nicergoline; Stroke | 2022 |
[Study of the effect of Unifuzol on cognitive impairment and damage to the hippocampus and cerebral cortex during course administration to rats with bilateral stenosis of the common carotid arteries, causing chronic circulatory failure].
Topics: Animals; Brain Ischemia; Carotid Artery, Common; Carotid Stenosis; Cognitive Dysfunction; Constriction, Pathologic; Cytidine Diphosphate Choline; Disease Models, Animal; Hippocampus; Male; Nicergoline; Rats; Shock | 2023 |